Related Experiment Videos

Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity

Ilaria Bellezza1, Arianna Tucci, Francesco Galli

  • 1Dipartimento di Medicina Sperimentale Scienze Biochimiche, Sezione Biochimica Cellulare, Università degli Studi di Perugia, via del Giochetto, Perugia, Italia. ilaria.bellezza@unipg.it

The Journal of Nutritional Biochemistry
|March 27, 2012
PubMed

Insights

α-Tocopheryl succinate (α-TOS) reduces prostate cancer cell viability by generating reactive oxygen species (ROS). It up-regulates heme oxygenase-1 (HO-1), which suppresses NF-κB signaling, offering a novel therapeutic insight.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • α-Tocopheryl succinate (α-TOS) induces cancer cell death via mitochondrial complex I and II inhibition and ROS generation.
  • Redox imbalance activates Nrf2, a transcription factor crucial for cellular protection and detoxification.
  • NF-κB signaling is implicated in cancer progression and inflammation.

Purpose of the Study:

  • To investigate the role of heme oxygenase-1 (HO-1) in mediating the effects of α-TOS on NF-κB signaling in prostate cancer cells.
  • To elucidate the mechanism by which short-term α-TOS exposure influences cellular redox balance and transcription factor activity.

Main Methods:

  • Prostate cancer cells were exposed to α-TOS for short durations (e.g., 4 hours).
  • Cell viability, ROS production, and glutathione (GSH) homeostasis were assessed.
  • Nuclear translocation of Nrf2 and NF-κB was analyzed.
  • The impact of HO-1 inhibition and its products (bilirubin, carbon monoxide) on NF-κB signaling was evaluated.

Main Results:

  • Short-term α-TOS exposure significantly reduced cell viability and moderately increased ROS production.
  • α-TOS induced a biphasic effect on GSH levels, with an initial decrease followed by a substantial rise.
  • α-TOS promoted Nrf2 nuclear translocation and up-regulated its downstream targets, including HO-1.
  • NF-κB nuclear translocation was decreased by α-TOS, an effect dependent on HO-1 activity.
  • Pharmacological inhibition of HO-1 reversed the α-TOS-mediated suppression of NF-κB.

Conclusions:

  • α-TOS up-regulates HO-1, which plays a critical role in inhibiting NF-κB nuclear translocation in prostate cancer cells.
  • This HO-1-dependent mechanism represents a novel pathway through which α-TOS exerts its anti-cancer effects.
  • Targeting the HO-1 pathway could be a potential therapeutic strategy for prostate cancer treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...